End of Day Message

LONDON, 18 Apr. 2025 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.

GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.

Disclaimer

The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.

If you have any questions about this message, please Contact Us.

You May Also Be Interested In

• Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
• Fall Wardrobe Quality Upgrade: COOFANDY Unveils Early Fall Menswear Preview
• Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis